Evidence map›Paper›PMID 36652913›Full record

ArticleCell reports. Medicine2023

Size matters in non-canonical inflammasome activation and cell-mediated immunity.

Adam M Weiss, Aaron P Esser-Kahn

Abstract readComment
PubMed Full text at PMC Publisher
In one paragraph

Article in Cell reports. Medicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

2 authors.

Adam M WeissPritzker School of Molecular Engineering, University of Chicago, 5640 South Ellis Avenue, Chicago, IL 60637, USA.
Aaron P Esser-KahnPritzker School of Molecular Engineering, University of Chicago, 5640 South Ellis Avenue, Chicago, IL 60637, USA. Electronic address: aesserkahn@uchicago.edu.

Funding

Discovery of adjuvants via novel modulation of innate immune pathways for vaccines against influenza75N93019C00041 · NIAID · UNIVERSITY OF CHICAGO · PI ESSER-KAHN, AARON · 2019 to 2024
$10.0M
NIAID NIH HHS 75N93019C00041
6 · The paper itself

Abstract

Particulate adjuvants are key components of many approved vaccines, but their mechanism of adjuvanticity is debated. Muñoz-Wolf et al.

Indexed as

InflammasomesNLR Family, Pyrin Domain-Containing 3 ProteinAdjuvants, ImmunologicCarrier ProteinsImmunity, CellularAdjuvants, ImmunologicCarrier ProteinsInflammasomesNLR Family, Pyrin Domain-Containing 3 Protein

Identifiers

PMID36652913
PMCPMC9873938

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.